Search Results 1471-1480 of 14761 for anti-TNF drugs

1. Testosterone (Topical Application Route) Precautions - Mayo Clinic

   The results of some tests may be affected by this medicine. Do not take other medicines unless they have been discussed with your doctor. This includes ...

2. Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic ... treatment with an anti-PD-1 or to have declined targeted therapy. Note ...

3. Abacavir, Dolutegravir, And Lamivudine (Oral Route) Before Using - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

4. A Study of MPDL3280A in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer - Mayo Clinic

   Participation eligibility · Any approved anti-cancer therapy within 3 weeks prior to initiation of study treatment · Treatment with any other investigational ...

5. Trastuzumab (Intravenous Route) Precautions - Mayo Clinic

   Use an effective form of birth control to keep from getting pregnant during therapy and for 7 months after the last dose of this medicine. If you think you have ...

6. Tremelimumab-Actl (Intravenous Route) Side Effects - Mayo Clinic

   Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

7. Peginterferon Alfa-2b (Subcutaneous Route) Side Effects - Mayo Clinic

   Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

8. Researchers seek to improve success of chimeric antigen receptor-T cell therapy in non-Hodgkin lymphoma - Mayo Clinic News Network

   The study is published in Cancer Discovery. "CAR-T cell therapy is a promising treatment for non-Hodgkin lymphoma, especially for patients who have relapsed or ...

9. A Study to Investigate the Effectiveness and Safety of Pf-04965842 in Subjects Aged 12 Years and Over, With Moderate to Severe Atopic Dermatitis with the Option of Rescue Treatment in Flaring Subjects - Mayo Clinic

   Herbal medications with unknown properties or known beneficial effects for AD. Within 1 week of first dose of investigational product: Anti-platelet drugs.

10. Clonidine Hydrochloride (Oral Route) Description and Brand Names - Mayo Clinic

    Descriptions. Clonidine extended-release suspension is used to treat attention deficit hyperactivity disorder (ADHD). It belongs to the group of medicines ...